Learn more

RESPIRATORIUS AB

Overview
  • Total Patents
    49
  • GoodIP Patent Rank
    193,201
About

RESPIRATORIUS AB has a total of 49 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are KANDY THERAPEUTICS LTD, JIANGSU VCARE PHARMATECH CO LTD and AUDIOCURE PHARMA GMBH.

Patent filings per year

Chart showing RESPIRATORIUS ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Skogvall Staffan 19
#2 Johansson Martin 19
#3 Toftered Joergen 9
#4 Dalence Maria 8
#5 Wensbo David 7
#6 Thornqvist Oltner Viveca 5
#7 Wokander Mats 4
#8 Berglund Magnus 3
#9 Dalence Guzman Maria 3
#10 Martin Johansson 3

Latest patents

Publication Filing date Title
KR20210032315A Novel bronchodilated heterolinked amide
CN104114191A Contrast agent for imagining myocardial perfusion
WO2010097410A1 Novel bronchodilating diazaheteroaryls
WO2009007418A1 Novel bronchodilating isoquinoline amides
WO2009007419A1 Novel bronchodilating isoquinoline carbamates
WO2009007420A1 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides
WO2008095852A1 Bronchorelaxing arylamides
WO2008041944A1 Device for drug screening
SE0602103L Device for drug testing and screening substances on tissue sample e.g. mammalian lung tissue and human small bronchi has force transducers which output signals for measuring contraction or relaxation of tissue sample
WO2007011290A1 Bronchorelaxing agents based on indol- and isoquinoline derivatives
CN1910149A Bronchorelaxing compounds
AU1117602A Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3
AU1288802A Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4)
AU2566301A A composition comprising a combination of receptor agonists and antagonists
AU5861900A Receptor agonists and antagonists
AU5259100A Medicament